4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-029093
Options or other derivatives
- Chief Financial Officer acquired 168,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bellemin Jean-Marc · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +168,750 | 168,750 | D |
Loading xslF345X03/tm238642-1_4seq1.xml…